Kate Lathrop, MD
Basic profileThe University of Texas at San Antonio Health Science Center
Kate Lathrop is an Oncology physician affiliated with The University of Texas at San Antonio Health Science Center. OpenAlex indexes 63 publications with 490 citations (h-index 10); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
7979 Wurzbach Rd
San Antonio, TX 782294427
Telephone
210-450-1143Registry record last updated 16 Jan 2019.
Clinical trials
- Clinical Trial of Avasopasem in Patients With Metastatic Hormone Receptor Positive Breast Cancer With Progression on a CDK 4/6 Inhibitor and Hormonal Therapy
Sponsor: The University of Texas Health Science Center at San Antonio
- S-equol in Women With Triple Negative Breast Cancer
Sponsor: The University of Texas Health Science Center at San Antonio
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
10 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Gilead Sciences, Inc.Program year20254 payments
- AstraZeneca Pharmaceuticals LPProgram year20251 payment
- PFIZER INC.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
88.7%PD-1 inhibitor83.2%Pembrolizumab100%Part B, office-administered≥14 patientsAromatase Inhibitor4.5%Anastrozole79%Letrozole12%Exemestane10%Part D<11 patients+ 2 more classes in this area
Sensory organs
3.8%Corticosteroid3.8%Dexamethasone sodium phosphate94%Dexamethasone6%Part D + Part B<11 patientsMetabolism & gastrointestinal
3.7%Serotonin-3 Receptor Antagonist3.7%Ondansetron hydrochloride94%Ondansetron Hcl6%Part D + Part B≥15 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Abstract PS4-03-13: Septin9 isoforms predict taxane efficacy in triple negative breast cancer
Clinical Cancer Research
2026 - Abstract B097: Empowering Latina breast cancer patients: A phone app + patient navigation to improve hormone therapy adherence
Cancer Epidemiology Biomarkers & Prevention
2025 - Abstract P4-03-24: Septin 9 isoform expression and response to taxane treatment in breast cancer patients
Clinical Cancer Research
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Marcos Restrepo, MD, MSc
The University of Texas at San Antonio Health Science Center
Robert Brzyski, MD
The University of Texas at San Antonio Health Science Center
Devjit Tripathy, MD
The University of Texas at San Antonio Health Science Center
Robert Svatek, MD
The University of Texas at San Antonio Health Science Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”